Today, CDC’s Director Rochelle P. Walensky, M.D., M.P.H., signed a call memo permitting Novavax monovalent COVID-19 boosters for adults.
This motion offers folks ages 18 years and older the choice to obtain a Novavax monovalent booster as a substitute of an up to date (bivalent) Pfizer-BioNTech or Moderna booster if they’ve accomplished major sequence vaccination however haven’t beforehand acquired a COVID-19 booster—and if they can not or won’t obtain mRNA vaccines.
Some could also be unable to obtain an mRNA vaccine on account of an allergy to a element of an mRNA COVID-19 vaccine, or on account of a historical past of a extreme allergic response (akin to anaphylaxis) after a earlier dose of an mRNA COVID-19 vaccine, or a scarcity of availability of an mRNA vaccine. People ages 18 and older may additionally select to obtain a Novavax monovalent booster if they’re unwilling to obtain mRNA vaccines, and would in any other case not obtain a booster dose.
FDA’s authorization of monovalent COVID-19 boosters and CDC’s advice to be used, are necessary steps ahead in our nation’s complete vaccination program—a program that has helped present elevated safety for all Americans in opposition to COVID-19 illness and demise.